Skip to content
February 03, 2023

Equity.Guru

Investment information for the new generation

Biotech

Cybin (CYBN.NEO), a Canadian-based biopharmaceutical company working to transform psychedelics into therapeutics, announced today that it had received approval from an independent ethics committee in the Netherlands to commence…
Specialty pharma company Medexus Pharmaceuticals (MDP.TO) announced today that it plans to host a conference call at 8:00 am EST on Wednesday November 9th 2022. The call will discuss…
Marvel Biosciences (MRVL.V), a Canadian life sciences company focused on the discovery and development of a synthetic derivative compound of know proven drugs, announced today that its wholly owned…
Cannabix Technologies (BLO.C), a Canadian-based company focused on developing tools for law enforcement and the workplace to detect THC in the breath, announced today that it had developed a…
Medexus Pharmaceuticals (MDP.TO) is a specialty pharma company that has been making big moves on the charts. The company is not a biotech company. They do not do research…
Medexus Pharmaceuticals (MDP.TO) is a specialty pharma company whose stock is on fire! The stock rallied 34% from its opening price to its highs last week. And it has…
BioMark Diagnostics (BUX.C), a Canadian biotech firm focused on developing its advanced-stage cancer detection business, released its year-end financial statement today. The company noted some important milestones it achieved…
Counting Sheep   For me, sleeping is both a blessing and a curse. While I love nothing more than laying in bed after a long day, I hate waking…
Kezar Life Sciences Inc. $561.261M Market Capitalization Between 2020 and 2021, year-over-year (YoY) funding in the biotech market increased by an impressive 39.6%. Currently, some of the biggest trends…
Last year Big Pharma unleashed 1,500 lobbyists to Washington, DC, who then cut cheques for $177 million to keep drug costs high. The lobbyists deserve bonuses. The average U.S….